While gallbladder-related issues are less common compared to other gastrointestinal side effects, they can cause significant discomfort for some patients, particularly during the dose-escalation phase and periods of rapid weight loss
Although many treatments effective in animal models of IRI have failed to translate into clinical use, glucagon-like peptide 1 (GLP-1) and the GLP-1 receptor (GLP-1R) agonist exenatide have shown benefits in IRI in both animal models (47) and small early-phase clinical trials (8, 9)
Common side effects include: Redness or discomfort at the injection site Mild swelling or joint stiffness Tingling in fingers or hands Water retention Less common side effects of tesamorelin include: Elevated blood sugar or insulin resistance Hand or foot swelling Allergic reactions (rare) Regular monitoring and consistent dosing reduce these risks significantly
Biomed Aging Pathol 3:179184
The longer a drug is in shortage, the more compounders begin creating it
Conditions that affect your small intestine such as Crohns disease, celiac disease, bacterial growth, or a parasite
